Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Statistics

Total Valuation

STO:XBRANE has a market cap or net worth of SEK 240.05 million. The enterprise value is 230.18 million.

Market Cap	240.05M
Enterprise Value	230.18M

Important Dates

The last earnings date was Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:XBRANE has 20.61 million shares outstanding. The number of shares has decreased by -94.75% in one year.

Current Share Class	20.61M
Shares Outstanding	20.61M
Shares Change (YoY)	-94.75%
Shares Change (QoQ)	+434.90%
Owned by Insiders (%)	16.69%
Owned by Institutions (%)	5.60%
Float	15.03M

Valuation Ratios

The trailing PE ratio is 2.26.

PE Ratio	2.26
Forward PE	n/a
PS Ratio	3.14
PB Ratio	0.44
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.17
EV / Sales	3.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.10.

Current Ratio	3.03
Quick Ratio	0.79
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.79

Financial Efficiency

Return on equity (ROE) is -20.41% and return on invested capital (ROIC) is -10.61%.

Return on Equity (ROE)	-20.41%
Return on Assets (ROA)	-5.20%
Return on Invested Capital (ROIC)	-10.61%
Return on Capital Employed (ROCE)	-10.34%
Weighted Average Cost of Capital (WACC)	8.95%
Revenue Per Employee	2.64M
Profits Per Employee	3.66M
Employee Count	28
Asset Turnover	0.11
Inventory Turnover	0.16

Taxes

In the past 12 months, STO:XBRANE has paid 2.32 million in taxes.

Income Tax	2.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.22% in the last 52 weeks. The beta is 0.89, so STO:XBRANE's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-65.22%
50-Day Moving Average	8.16
200-Day Moving Average	16.30
Relative Strength Index (RSI)	67.92
Average Volume (20 Days)	62,104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:XBRANE had revenue of SEK 76.45 million and earned 106.01 million in profits. Earnings per share was 4.80.

Revenue	76.45M
Gross Profit	43.43M
Operating Income	-56.88M
Pretax Income	-75.88M
Net Income	106.01M
EBITDA	-58.75M
EBIT	-56.88M
Earnings Per Share (EPS)	4.80

Balance Sheet

The company has 66.75 million in cash and 56.88 million in debt, with a net cash position of 9.87 million or 0.48 per share.

Cash & Cash Equivalents	66.75M
Total Debt	56.88M
Net Cash	9.87M
Net Cash Per Share	0.48
Equity (Book Value)	550.16M
Book Value Per Share	26.70
Working Capital	245.07M

Cash Flow

Operating Cash Flow	-190.55M
Capital Expenditures	n/a
Depreciation & Amortization	-1.87M
Net Borrowing	36.51M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 56.81%, with operating and profit margins of -74.40% and 138.65%.

Gross Margin	56.81%
Operating Margin	-74.40%
Pretax Margin	-99.25%
Profit Margin	138.65%
EBITDA Margin	-76.84%
EBIT Margin	-74.40%
FCF Margin	n/a

Dividends & Yields

STO:XBRANE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	94.75%
Shareholder Yield	94.75%
Earnings Yield	44.16%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 17, 2025. It was a reverse split with a ratio of 0.008.

Last Split Date	Oct 17, 2025
Split Type	Reverse
Split Ratio	0.008

Scores

STO:XBRANE has an Altman Z-Score of 0.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.18
Piotroski F-Score	2